Premark Pharma
Treatments of ophthalmic diseases
The company specializes in the development and commercialization of topical treatments for inflammatory diseases of the skin, eye, mucosae, and mucocutaneous surfaces, enabling doctors to cure patients suffering from unmet conditions.
Domain
Topical Ophthamology
First Partnered
Seed
Current Status
Active
Investors
Tom Mather
Leadership
John Wayne, CEO
Ann Smith, CTO
HQ
Distributed